vs
Ascendis Pharma A/S（ASND）与COMPASS MINERALS INTERNATIONAL INC（CMP）财务数据对比。点击上方公司名可切换其他公司
COMPASS MINERALS INTERNATIONAL INC的季度营收约是Ascendis Pharma A/S的1.5倍（$396.1M vs $267.3M），Ascendis Pharma A/S同比增速更快（42.3% vs 28.9%），过去两年Ascendis Pharma A/S的营收复合增速更高（60.7% vs 4.3%）
Ascendis Pharma A/S是一家聚焦内分泌疾病治疗领域的生物制药企业，核心业务覆盖生长激素疗法的研发、生产与商业化。其依托重组DNA技术生产的生长激素类处方药物，可用于治疗多种生长激素缺乏相关适应症，临床应用场景广泛。
指南针矿产国际是一家美国上市矿产企业，总部位于堪萨斯州欧弗兰帕克，是盐、氯化镁和硫酸钾等产品的领先生产商。公司面向北美和英国客户供应经处理与未经处理的散装道路除冰盐，同时向全球种植者提供植物营养产品，此外也生产民用除冰、水质调节产品及相关商用产品。
ASND vs CMP — 直观对比
营收规模更大
CMP
是对方的1.5倍
$267.3M
营收增速更快
ASND
高出13.4%
28.9%
两年增速更快
ASND
近两年复合增速
4.3%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $267.3M | $396.1M |
| 净利润 | — | $18.6M |
| 毛利率 | 90.5% | 16.0% |
| 营业利润率 | — | 9.2% |
| 净利率 | — | 4.7% |
| 营收同比 | 42.3% | 28.9% |
| 净利润同比 | — | 178.8% |
| 每股收益（稀释后） | — | $0.43 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASNDCMP
| Q4 25 | $267.3M | $396.1M | ||
| Q3 25 | $230.7M | $227.5M | ||
| Q2 25 | $170.7M | $214.6M | ||
| Q1 25 | $109.0M | $494.6M | ||
| Q4 24 | $187.8M | $307.2M | ||
| Q3 24 | $62.5M | $208.8M | ||
| Q2 24 | $38.9M | $202.9M | ||
| Q1 24 | $103.6M | $364.0M |
净利润ASNDCMP
| Q4 25 | — | $18.6M | ||
| Q3 25 | $-65.9M | $-7.2M | ||
| Q2 25 | $-42.0M | $-17.0M | ||
| Q1 25 | $-102.2M | $-32.0M | ||
| Q4 24 | — | $-23.6M | ||
| Q3 24 | $-107.1M | $-48.3M | ||
| Q2 24 | $-118.1M | $-43.6M | ||
| Q1 24 | $-141.5M | $-38.9M |
毛利率ASNDCMP
| Q4 25 | 90.5% | 16.0% | ||
| Q3 25 | 89.5% | 16.9% | ||
| Q2 25 | 80.1% | 19.2% | ||
| Q1 25 | 82.6% | 15.5% | ||
| Q4 24 | 91.9% | 11.2% | ||
| Q3 24 | 80.6% | 9.3% | ||
| Q2 24 | 68.2% | 16.1% | ||
| Q1 24 | 92.1% | 19.7% |
营业利润率ASNDCMP
| Q4 25 | — | 9.2% | ||
| Q3 25 | 5.1% | 5.3% | ||
| Q2 25 | -33.5% | 7.4% | ||
| Q1 25 | -103.2% | -0.6% | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | -167.3% | -14.3% | ||
| Q2 24 | -370.2% | 2.9% | ||
| Q1 24 | -51.2% | -10.8% |
净利率ASNDCMP
| Q4 25 | — | 4.7% | ||
| Q3 25 | -28.5% | -3.2% | ||
| Q2 25 | -24.6% | -7.9% | ||
| Q1 25 | -93.7% | -6.5% | ||
| Q4 24 | — | -7.7% | ||
| Q3 24 | -171.5% | -23.1% | ||
| Q2 24 | -303.9% | -21.5% | ||
| Q1 24 | -136.6% | -10.7% |
每股收益（稀释后）ASNDCMP
| Q4 25 | — | $0.43 | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $-0.41 | ||
| Q1 25 | — | $-0.77 | ||
| Q4 24 | — | $-0.57 | ||
| Q3 24 | — | $-1.17 | ||
| Q2 24 | — | $-1.05 | ||
| Q1 24 | — | $-0.94 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $665.3M | $46.7M |
| 总债务越低越好 | — | $890.0M |
| 股东权益账面价值 | $-175.8M | $260.5M |
| 总资产 | $1.4B | $1.5B |
| 负债/权益比越低杠杆越低 | — | 3.42× |
8季度趋势，按日历期对齐
现金及短期投资ASNDCMP
| Q4 25 | $665.3M | $46.7M | ||
| Q3 25 | $582.2M | $59.7M | ||
| Q2 25 | $533.6M | $79.4M | ||
| Q1 25 | $559.4M | $49.5M | ||
| Q4 24 | $604.3M | $45.8M | ||
| Q3 24 | $675.6M | $20.2M | ||
| Q2 24 | $279.4M | $12.8M | ||
| Q1 24 | $345.9M | $38.3M |
总债务ASNDCMP
| Q4 25 | — | $890.0M | ||
| Q3 25 | — | $839.8M | ||
| Q2 25 | — | $833.4M | ||
| Q1 25 | — | $807.6M | ||
| Q4 24 | — | $974.4M | ||
| Q3 24 | — | $921.2M | ||
| Q2 24 | — | $875.1M | ||
| Q1 24 | — | $877.2M |
股东权益ASNDCMP
| Q4 25 | $-175.8M | $260.5M | ||
| Q3 25 | $-188.0M | $234.1M | ||
| Q2 25 | $-202.6M | $249.8M | ||
| Q1 25 | $-205.0M | $236.5M | ||
| Q4 24 | $-114.2M | $263.0M | ||
| Q3 24 | $-105.1M | $316.6M | ||
| Q2 24 | $-346.8M | $352.1M | ||
| Q1 24 | $-257.2M | $400.4M |
总资产ASNDCMP
| Q4 25 | $1.4B | $1.5B | ||
| Q3 25 | $1.2B | $1.5B | ||
| Q2 25 | $1.2B | $1.5B | ||
| Q1 25 | $1.1B | $1.5B | ||
| Q4 24 | $1.3B | $1.7B | ||
| Q3 24 | $1.2B | $1.6B | ||
| Q2 24 | $819.0M | $1.6B | ||
| Q1 24 | $866.7M | $1.7B |
负债/权益比ASNDCMP
| Q4 25 | — | 3.42× | ||
| Q3 25 | — | 3.59× | ||
| Q2 25 | — | 3.34× | ||
| Q1 25 | — | 3.41× | ||
| Q4 24 | — | 3.70× | ||
| Q3 24 | — | 2.91× | ||
| Q2 24 | — | 2.49× | ||
| Q1 24 | — | 2.19× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $58.2M | $-37.0M |
| 自由现金流经营现金流 - 资本支出 | — | $-59.8M |
| 自由现金流率自由现金流/营收 | — | -15.1% |
| 资本支出强度资本支出/营收 | — | 5.8% |
| 现金转化率经营现金流/净利润 | — | -1.99× |
| 过去12个月自由现金流最近4个季度 | — | $94.1M |
8季度趋势，按日历期对齐
经营现金流ASNDCMP
| Q4 25 | $58.2M | $-37.0M | ||
| Q3 25 | — | $-6.9M | ||
| Q2 25 | — | $21.8M | ||
| Q1 25 | $-15.5M | $186.9M | ||
| Q4 24 | $-330.7M | $-4.1M | ||
| Q3 24 | — | $-12.7M | ||
| Q2 24 | — | $-6.8M | ||
| Q1 24 | $-109.7M | $86.2M |
自由现金流ASNDCMP
| Q4 25 | — | $-59.8M | ||
| Q3 25 | — | $-22.8M | ||
| Q2 25 | — | $3.8M | ||
| Q1 25 | — | $172.9M | ||
| Q4 24 | — | $-25.9M | ||
| Q3 24 | — | $-33.6M | ||
| Q2 24 | — | $-21.5M | ||
| Q1 24 | — | $56.2M |
自由现金流率ASNDCMP
| Q4 25 | — | -15.1% | ||
| Q3 25 | — | -10.0% | ||
| Q2 25 | — | 1.8% | ||
| Q1 25 | — | 35.0% | ||
| Q4 24 | — | -8.4% | ||
| Q3 24 | — | -16.1% | ||
| Q2 24 | — | -10.6% | ||
| Q1 24 | — | 15.4% |
资本支出强度ASNDCMP
| Q4 25 | — | 5.8% | ||
| Q3 25 | — | 7.0% | ||
| Q2 25 | — | 8.4% | ||
| Q1 25 | — | 2.8% | ||
| Q4 24 | — | 7.1% | ||
| Q3 24 | — | 10.0% | ||
| Q2 24 | — | 7.2% | ||
| Q1 24 | — | 8.2% |
现金转化率ASNDCMP
| Q4 25 | — | -1.99× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASND
暂无分部数据
CMP
| Highway Deicing Salt | $210.8M | 53% |
| Consumer Industrial Salt | $120.7M | 30% |
| Plant Nutrition | $60.8M | 15% |
| Transferred Over Time | $2.8M | 1% |
| Other | $1.0M | 0% |
